Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

MHRA grants marketing authorisation for new formulation of Tysabri

April 16, 2021 Medical Communications MHRA

Biogen UK has been granted marketing authorisation by the MHRA for a subcutaneous (SC) injection of Tysabri (natalizumab), for adults …
News

Merck cease development of $425 million COVID-19 treatment

April 16, 2021 Medical Communications COVID-19, MSD, Merck, covid-19 treatment, pharma, pharma news

Merck (MSD) have ended the development of their MK-7110 drug for the treatment of hospitalised patients with COVID-19.
News

EMA to begin review of GSK and Vir’s COVID-19 treatment

April 16, 2021 Medical Communications COVID-19, EMA, GSK, covid-19 treatment, pharma, pharma news, vir

The EMA have begun a review of GSK and Vir Biotechnology’s investigational COVID-19 antibody (VIR-7831) for patients at high risk …
News
andrei_r_-_shutterstock_1935537274_720

Thermo Fisher to acquire PPD in $17 billion deal

April 16, 2021 Medical Communications thermo fisher

Medical device maker Thermo Fisher Scientific announced it would acquire contract research organisation PPD Inc for $17.4 billion, as it …
News
Top 10 news roundup

Pharmafile.com’s top 10 news stories of the week

April 9, 2021 Medical Communications covid 19 news, covid-19 news, news, news roundup, pharma, pharma news

A number of new COVID-19 developments have emerged in April already: AstraZeneca has halted the trial of its COVID-19 vaccine …
News

Exscientia enter first-ever AI cancer drug into Phase I trials

April 9, 2021 Medical Communications AI, Evotec, Exscientia, cancer treatment, oncology, pharma, pharma news

Exscientia and Evotec have announced that they are entering an AI-designed immuno-oncology drug into Phase I trials for the first …
News
moderna_norwood_plant

Moderna publishes antibody persistence data of COVID-19 vaccine

April 9, 2021 Medical Communications

Moderna have published antibody persistence data out to six months following the second dose of its COVID-19 vaccine (mRNA-1273) in …
News
lilly_entrance_web

Lily and Incyte Phase III COVID-19 study fails to meet primary endpoint

April 9, 2021 Medical Communications COVID-19, Eli Lily

Results from Eli Lily and Incyte’s Phase III study, COV-BARRIER, evaluating baricitinib in the treatment of hospitalised COVID-19 patients did …
News
abbottweb

Abbott receives CE mark approval for TriClip device

April 9, 2021 Medical Communications

Abbott have received CE Mark approval for its next-generation TriClip Transcatheter Tricuspid Valve Repair System, the first-of-its-kind tricuspid heart valve …
News

Intravac appoints Nathalie Laarakker as CFO

April 7, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Intravac have announced the appointment of Nathalie Laarakker as its new CFO and member of the company’s executive management team. …
Appointment

Smithers promotes Nikki Lucas to Principal Project Manager

April 7, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Nikki Lucas has been appointed Principal Project Manager within Smithers’ Medical Device Physical Testing team. Lucas has over a decade …
Appointment

New CEO appointed at Nordic Nanovector

April 7, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Nordic Nanovector have appointed Peter Braun as their new Chief Executive Officer. Braun is an experienced and entrepreneurial pharmaceutical leader, …
Appointment
chas_taylor

Ceryx Medical announce new chairman Chas Taylor

April 7, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Cardiovascular technology company Ceryx Medical have appointed Chas Taylor as their new chairman. The appointment comes at an interesting time …
Appointment
Top 10 news roundup

Pharmafile.com’s top 10 news stories of the week

March 26, 2021 Medical Communications AstraZeneca vaccine, COVID-19, covid 19 news, covid-19 news, news, news roundup, starpharma

In the last week, a number of new developments have made the news; for COVID-19, Starpharma will begin to sell …
News

FDA approve Astellas’s Myrbetriq treatment for bladder dysfunction

March 26, 2021 Medical Communications Astellas Pharma, FDA, Ida approval

The FDA have approved a new indication for Astellas Pharma’s Myrbetriq and Myrbetriq Granules to treat neurogenic detrusor overactivity (NDO), …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026